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Abstract
Rod-cone dysplasia type 2 (rcd2) is an autosomal recessive disorder that segregates in collie dogs. Linkage
disequilibrium and meiotic linkage mapping were combined to take advantage of population structure within
this breed and to fine map rcd2 to a 230-kb candidate region that included the gene C1orf36 responsible for
human and murine rd3, and within which all affected dogs were homozygous for one haplotype. In one of
three identified canine retinal RD3 splice variants, an insertion was found that cosegregates with rcd2 and is
predicted to alter the last 61 codons of the normal open reading frame and further extend the open reading
frame. Thus, combined meiotic linkage and LD mapping within a single canine breed can yield critical
reduction of the disease interval when appropriate advantage is taken of within-breed population structure.
This should permit a similar approach to tackle other hereditary traits that segregate in single closed
populations.
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Abstract
Rod cone dysplasia type 2 (rcd2) is an autosomal recessive disorder that segregates in collie dogs.
Linkage disequilibrium and meiotic linkage mapping were combined to take advantage of population
structure within this breed, and to fine map rcd2 to a 230 kb candidate region that included the gene
C1orf36 responsible for human and murine rd3, and within which all affected dogs were homozygous
for one haplotype. In one of three identified canine retinal RD3 splice variants, an insertion was found
that cosegregates with rcd2, and is predicted to alter the last 61 codons of the normal open reading
frame and further extend the ORF. Thus combined meiotic linkage and LD mapping within a single
canine breed can yield critical reduction of the disease interval when appropriate advantage is taken
of within breed population structure. This should permit a similar approach to tackle other hereditary
traits that segregate in single closed populations.
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Introduction
The development of modern dog breeds has created a population structure that is largely
separated into relatively closed subpopulations termed breeds. The traits that define each such
breed include both those deliberately bred for, and undesirable traits concentrated into
particular breeds by descent from a small founder pool. As information about the canine
genome became increasingly available, it quickly became apparent that, in general, linkage
disequilibrium (LD) within breeds can spread to several megabases, but across breeds LD only
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extends over tens of kilobases (Lindblad-Toh et al. 2005). This has suggested that the dog is
particularly advantageous for gene mapping studies, as the large LD within a breed would
require a correspondingly smaller number of markers for association mapping studies in dogs
compared to humans (Sutter et al. 2004; Lindblad-Toh et al. 2005). Furthermore, when a trait
segregates in multiple breeds, fine mapping across these breeds can very efficiently narrow the
candidate region by taking advantage of the reduced LD interval common to all such breeds
(Karlsson et al., 2007). Several identical-by-descent (IBD) mutations have been fine mapped
in this manner (Neff et al. 2004; Goldstein et al. 2006; Sutter et al. 2007; Parker et al. 2007;
Candille et al. 2007). In previous studies we employed this strategy to fine map two canine
hereditary retinal disorders, collie eye anomaly (Parker et al. 2007) and progressive rod cone
degeneration (Goldstein et al. 2006). Both of these diseases segregated in multiple breeds, and
fine mapping between such breeds rapidly reduced the initially identified candidate region to
yield the subsequently identified causative mutations (Zangerl et al. 2006; Parker et al.
2007). Retrospective analysis of these studies, however, suggested that in both cases, a careful
selection of individuals based on population structure, would have resulted in the same
progress, even if restricted to a single breed per disease. The significance of this observation
has been strengthened by independent reports of stratified linkage disequilibrium within single
breeds (Quignon et al. 2007; Bjornerfeldt et al. 2008). Successful implementation of this
strategy would facilitate mapping and fine mapping of traits that are only known to segregate
in single specific breeds.
Rod-cone dysplasia type 2 (rcd2) is one of the many canine hereditary retinal degenerations
that are collectively named progressive retinal atrophy (PRA) (Aguirre and Acland 2006).
Some forms of PRA are common to multiple dog breeds, while others are recognized in just a
single breed (Acland et al. 1998; Acland et al. 1999; Zeiss et al. 2000; Kijas et al. 2002;
Goldstein et al. 2006; Zangerl et al. 2006; Mellersh et al. 2006). As far as is known, rcd2
segregates exclusively in rough and smooth collies (Wolf et al. 1978). The disease is inherited
as a simple autosomal recessive trait and has been previously characterized
electrophysiologically, morphologically and biochemically (Santos-Anderson et al. 1980;
Woodford et al. 1982; Chader et al. 1985; Acland et al. 1989). Night blindness is the earliest
clinical sign detectable in 6-week-old affected dogs. Retinal dysfunction can be detected by
electroretinography (ERG) as early as 16 days of age. At 6 weeks of age, when the
photoreceptors of normal dogs are fully developed, only a few underdeveloped outer segments
are visible in rcd2 dogs; by 2–2.5 months age, the outer segments completely disappear in the
affected retina. Both rods and cones in the affected retina fail to develop normal outer segments
(Santos-Anderson et al. 1980). Both types of photoreceptors subsequently degenerate, cones
more slowly than rods. Ophthalmoscopic abnormalities can be detected at 3.5 to 4 months of
age, including tapetal hyperreflectivity, retinal vascular attenuation and optic nerve pallor. By
6 to 8 months of age rcd2 dogs become functionally blind. The rcd2 locus has been mapped
previously to a ~4 Mb region on CFA7, an interval homologous to human 1q32 (Kukekova et
al. 2006).
In the present study a combination of meiotic linkage and linkage disequilibrium mapping,
together with critical pedigree analysis, was employed to fine map and reduce this interval.
Meiotic mapping utilized both additional, newly developed informative pedigrees, and
additional microsatellite markers located within the previously identified zero recombination
region. In parallel, a dense SNP map of the region was simultaneously developed to permit
haplotype analysis and linkage disequilibrium mapping. In combination, these two approaches
reduced the candidate region to an approximately 230 Kb interval on CFA7 that contained only
three known genes (TRAF5, C1orf36, and SLC30A1). All three genes are retinal expressed and
were thus potential positional candidates for rcd2. Comparative genomic analysis disclosed
that the reduced canine rcd2 interval overlapped with the murine retinal degeneration 3 (rd3)
locus on Mmu1 (Danciger et al. 1999). Simultaneously, and independently, the C1orf36 gene
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was identified as harboring the causative mutations for both murine rd3 and the homologous
human disease (Friedman et al. 2006). This gene has now been renamed RD3. Sequence of the
canine RD3 coding region was retrieved from retinal cDNA. Unlike mouse and human RD3,
that each have a single known transcript (Lavorgna et al. 2003; Friedman et al. 2006), three
canine retinal RD3 splice variants were detected. A sequence alteration identified in one of
these variants between normal and rcd2 affected individuals is proposed as the cause of canine
rcd2.
Methods
To fine map and reduce the rcd2 candidate region a 2-pronged approach was adopted. First,
for meiotic linkage purposes the previously mapped families were significantly expanded (see
below) to provide an additional 140 informative progeny. Both the previously mapped and
newly developed pedigrees were then genotyped for a much denser set of microsatellites
identified from the canine genome assembly as located within the region. Secondly, and
simultaneously, a dense SNP map of the candidate region was developed to permit haplotype
analysis and linkage disequilibrium mapping of the candidate region.
I. Pedigrees and DNA samples
Blood and or tissue samples were obtained from dogs in rcd2-informative collie-derived
mixed-breed pedigrees developed at the Retinal Disease Studies Facility in Kennett Square,
PA. Additional blood samples for DNA analysis were obtained from privately owned dogs
representative of the USA pedigreed collie population. These pedigreed collies included both
rough and smooth varieties of the breed. It should be noted that internationally these varieties
are classified as separate breeds, and are not bred to each other, but they form a single breed
registry in the USA. Extended pedigrees of rcd2-affected collies were obtained from historical
records provided by collie breeders and analysed by inspection to detect patterns of common
ancestry. Further blood samples for DNA analysis were obtained for population studies from
privately owned dogs representing 19 other breeds. Samples used for meiotic linkage analysis
represented 14 three-generation pedigrees (126 individuals in the informative generation)
previously used for an rcd2 genome wide scan (Kukekova et al. 2006), and a further 26
backcross and intercross pedigrees including 140 informative progeny. LD mapping was
performed using samples from 7 rcd2-affected and 3 rcd2-carrier (obligate-heterozygous)
collie dogs. DNA from canine tissue samples (blood, spleen) was extracted using either Qiagen
Mini and Maxi Blood kits (Qiagen, CA) or phenol-chloroform extraction methods (Gilbert and
Vance 1994).
II. Microsatellite markers and linkage analysis
Three microsatellite markers (FH2226, FH3972, and VIASD10) were chosen that defined the
previously identified rcd2 interval (Kukekova et al. 2006), plus a fourth (CPH20) from the
corresponding interval of the canine integrated genome map (Guyon et al. 2003).
Potential additional microsatellites from this interval were identified from CanFam2 (the May
2005 assembly of the 7.6x canine genome sequence) using the RepeatMasker track of the
UCSC browser (http://genome.ucsc.edu/cgi-bin/hgGateway?org=Dog&db=canFam2), and
primer pairs for each were designed using Primer3. Such potential markers were tested for
informativeness on DNA representing four dogs from the parental generation of rcd2-
informative pedigrees using standard PCR conditions: an initial 2 min denaturation at 96°C;
then 30 cycles of 96°C (20 seconds), 58°C (20 seconds), 72°C (20 seconds); and a final
extension step at 72°C for 5 minutes. PCR products were resolved on 10% native
polyacrylamide gel and visualized by Ethidium bromide staining. Five such markers that
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proved polymorphic were selected for genotyping (SYT14F3/R3, SERTAD4F1/R1,
KCNH1F3/R3, rcd2ms3F1/R1, rcd2ms6F1/R1; see Table 1).
For fine mapping and linkage analysis, pedigrees were genotyped with markers FH2226,
CPH20, SYT14F3/R3, KCNH1F3/R3, FH3972, and VIASD10 using fluorescently labeled
primers. PCRs were performed in a 15 μl mixture containing 1X Invitrogen Taq Polymerase
buffer, 1.5 mM MgCl2, 0.2mM of dNTP, 0.3 pmol of each primer, 1.5 ng of canine DNA, and
0.5 units of Invitrogen Taq Polymerase. Amplification conditions were as described above for
amplification with unlabeled primers except that the final extension time was for one hour.
PCR products were combined into a multiplex set and analyzed on an ABI3730 capillary-based
Genetic Analyzer (PE Biosystems, Foster City, CA). PCR products were sized relative to an
internal size standard (GeneScan 500 LIZ) using ABI Genemapper 3.5 software package (PE
Biosystems, Foster City, CA). Quality parameters were established using ABI Genemapper
3.5 and genotypes were double scored by independent investigators.
III. SNP markers
SNP markers for the rcd2 interval were selected from the canine SNP database
(http://www.broad.mit.edu/mammals/dog/snp/). Primers for amplification were designed
using Primer3 (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). Identified SNPs
were amplified on DNA from 3 to 7 rcd2 affected and 1 to 3 carrier dogs using the same PCR
conditions described above for PCR with unlabeled primers. Robustly amplified PCR products
were sequenced and analyzed using Sequencher software (Gene Codes Corporation, MI).
Informative SNPs were used for haplotype analysis (Figure 1B, Supplementary Table 1).
IV. RNA
Total RNA was extracted from retinas of normal and rcd2 affected dogs using TRIZOL reagent
(Ambion, TX). Time points included 1.4 to 1.9 weeks, 3.3 to 4.3 weeks, 6.4 to 7.9 weeks, and
9.7 to 10.3 weeks with a normal and rcd2 affected dog for each time point.
IV.1. RT-PCR
IV.1.a: To evaluate the rcd2 gene, primers for RT-PCR were designed from RD3 sequence
retrieved from the 7.6x assembly of the canine genome (CanFam2), to cover the complete
coding sequence (Table 2). Since the predicted exon 4 of this gene is missing from CanFam2
and it was not found in canine sequences from any other database, primers within exon 4 were
designed from human RD3 sequence in regions highly conserved among human, mouse,
chicken and opossum genomes. Once the canine sequence was retrieved from RT-PCR
reactions, canine primers were designed to further improve the efficiency of reactions (Table
2A). cDNA was prepared using Thermoscript RT (Invitrogen, CA) following the
manufacturer’s protocol using an extension temperature of 600C. PCR reactions were run using
GoTaq green master mix (Promega, WI) following the manufacturer’s protocol with 5%
DMSO and annealing temperature in the range of 620C to 660C.
To identify the 5’ and 3’ ends of the transcript, 5’ RACE and 3’ RACE was undertaken on 10.4
weeks old normal canine retinal RNA using RACE kit BD Advantage following the
manufacturer’s protocol (Clontech, CA). 5’ RACE-PCR with primer 36F9 and 3’ RACE-PCR
with primer 36R1A were performed. PCR products were cloned into TOPO vector pCR2.1
(Invitrogen, CA). Two 3′ RACE and a 5′ RACE sequence were aligned using Sequencher, to
identify an initial consensus canine RD3 cDNA sequence.
IV.1.b: TRAF5 retinal cDNA of one normal and one rcd2 affected dogs was amplified using
RT-PCR with primers TR1F/TR1R, TR4F/TR3R, TR7F/TR10R, TR4F/TR7R, and TR6F/
TR9R (Supplementary Table 2; NCBI Accession: EU687744).
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IV.1.c: Partial canine SLC30A1 retinal cDNA was amplified using RT-PCR with primers
SL1F/ SL3F/SL2R, SL6F/SL6R. Products corresponding to coding regions of the SLC30A1
gene were also amplified from canine genomic DNA using primers SL1F/SL1R, SL4F/SL3R,
SL5F/SL5R (Supplementary Table 2). All products were amplified from retinal cDNA or
genomic DNA from at least one normal and one rcd2-affected dog, and sequenced, NCBI
Accession: EU687743.
IV.2. Northern analysis—Northern analysis was performed as described previously
(Goldstein et al. 2006). Eleven retinal RNA probes from time points ranging from 1.4 weeks
to 10.3 weeks old were analyzed. An RD3 probe was produced by amplification of cDNA with
primers 36F18/36R1. The resulting probe comprises RD3 cDNA fragment from exon 1 through
exon 3, primer location is listed in Table 2. The 737 bp PCR product was gel purified, cloned
(TOPO TA cloning kit, Invitrogen, CA) and used for blot hybridization. Hybridization was
carried out using Ultrahyb solution (Ambion, TX) following the manufacturer’s protocol. The
blot was exposed to X-ray film at –700C for 72 hours using two intensifying screens. Loading
control was achieved by hybridizing a canine β-actin probe to the membrane under the same
conditions and exposure to X-ray film for 5 hours. Northern images were scanned on a Fuji
Bio-Imaging Analyzer and scored by MacBAS software.
V. Cloning and sequencing of the gap region
To obtain sequence representing the genomic fragment of canine RD3 that is absent from the
CanFam2 assembly, two canine BAC clones CH82-166H15 and CH82-417I05 (Boxer BAC
library, http://bacpac.chori.org/library.php?id=253) were selected from the UCSC database
(http://genome.ucsc.edu/). BAC DNA was digested with selected restriction enzymes and
hybridized with canine RD3 probes #1 (RD3F2/R2) and #2 (RD3F4/R4) located before and
after the gap in the CanFam2.0, respectively, and a probe #3 (36e2F1c/36e2ogR16)
corresponding to a part of the canine RD3 exon 4. Primers used for probe amplification are
listed in Table 2C. A PstI fragment, about 1.5 Kb, identified from BAC clone CH82-166H15,
and tested positive for probes 1 and 3, and a PstI fragment ~4.5 Kb identified from BAC clone
CH82-417I05 that was positive for probes 2 and 3, were both cloned into vector pUC19 at the
corresponding restriction sites. The p166-18 plasmid (~1.5 Kb insertion) was sequenced using
plasmid specific and RD3 specific primers (Supplementary Table 3). A large part of the p417–
19 plasmid (~4.5 Kb insertion) was also sequenced in the same manner but the sequence failed
to read through a GC-rich region of the insertion. To obtain this GC-rich sequence, the p417–
19 plasmid was digested with restriction enzyme PvuII and an approximately 1.1 Kb fragment
was subcloned into the pUC19 SmaI restriction site. The cloned fragment was sequenced using
plasmid specific and RD3 specific primers (Supplementary Table 3, Supplementary Fig. 1).
Sequence of the canine RD3 fragment corresponding to the 1,552 bp gap region in CanFam2
(CFA7: 12,832,685-12,834,236) was submitted to the NCBI database (NCBI Accession:
EU687745).
VI. Mutation screening in normal and affected dogs
Because of the GC-rich nature of the canine RD3 gene (see below) genomic DNA was
deaminated prior to PCR amplification using primer pair RD3NH3F1/RD3NH3R1 (see Table
2B). Deamination was undertaken using EZ Methylation-Gold Kit (Zymo Research, CA)
following the manufacturer’s protocol except that the deamination step was extended to 5 hours
and the starting amount of DNA was reduced to 250 ng. PCR on deaminated DNA was
performed under the following conditions: an initial 2 minutes denaturation at 96°C; then 30
cycles of 96°C (20 seconds), 58°C (20 seconds), 72°C (20 seconds); and a final extension step
at 72°C for 5 minutes. PCR products were separated on 6% nondenaturing polyacrilamide gel.
18 rcd2 affected individuals, 13 rcd2 obligate carriers, and 110 dogs not known to be affected
with rcd2 from 20 breeds were tested by PCR for presence of the RD3 insertion.
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Results
I. Fine mapping the rcd2 locus
I.1. Linkage mapping—Six individuals from the previously published rcd2 pedigree set
were recombinant in the ~4.0 Mb interval flanked by markers FH2226 and FH3972 (CFA7:
9,035,490 – 12,950,649 bp, CanFam2). Four of these, recombinant between FH2226 and
rcd2, defined the centromeric end of the zero recombination interval. The other two,
recombinant between rcd2 and FH3972 defined the telomeric end. Genotyping the pedigrees
that included these recombinant offspring with additional informative microsatellite markers
CPH20, REN314O07 and FH1031, identified one individual as recombinant between CPH20
and rcd2, thus shifting the centromeric boundary of the zero recombination interval, and
reducing this interval to approximately 2.5 Mb (CFA7: 10,014,511 – 12,595,819 bp, CanFam2;
Figure 1A).
Genotyping all previously identified recombinant individuals plus 22 additional rcd2-
informative pedigrees (140 individuals) with 6 markers (CPH20, SYT14, SERTAD4, KCNH1,
FH3972, and VIASD10) identified a recombination between rcd2 and centromerad marker
KCNH1 (CFA7, Figure 2A; Table 1), but identified no further recombinations within the
interval. Genotyping the pedigree that included this recombinant dog with another 2 markers
(rcd2ms3 and rcd2ms6) established that its recombination was between rcd2ms6 and rcd2
(Figure 2A), which further reduced the rcd2 zero recombination interval to the approximately
308 Kb distance between markers rcd2ms6 and FH3972 (12,642,574–12,950,649 bp; Figure
1). This reduced interval included five known genes (RCOR3, GOLT1B, TRAF5, C1orf36
(RD3), and SLC30A1) on CanFam2.
I.2. Pedigree Analysis, Haplotype Analysis and LD mapping
I.2. a. Pedigree Analysis: Pedigree analysis was undertaken on multiple rcd2-affected
pedigreed collie dogs that were either founders of the rcd2-informative collie-derived pedigrees
used for linkage mapping, or privately owned rcd2-affected pedigreed collies. From this
analysis, the pedigrees of purebred collies could be separated into three distinct subpopulations.
In the largest of these subpopulations, the pedigrees of rcd2-affected collies showed a similar
pattern of several inbreeding loops within recent (4 to 10) generations, and all these dogs shared
one or another of a small number of closely related recent common ancestors contributing to
both their maternal and paternal lines of descent. As well, further descendants of these common
ancestors included several additional dogs that were known historically to be affected with
rcd2. This clearly suggested that the rcd2 disease alleles in this subpopulation were all inherited
identical-by-descent from a recent common ancestor (data not shown).
In contrast, two rcd2-affected pedigreed collies each demonstrated very different pedigree
structures, both from each other and from the majority of rcd2-affected pedigreed collies (i.e.
from subpopulation 1). In both of these 2 dogs’ pedigrees there was a single inbreeding loop
producing the affected dog, no further inbreeding loops were present within recent (4–6)
generations, and no ancestor was recognized as being historically affected by PRA. In addition,
neither of these 2 pedigrees included any dogs identified as recent common ancestors in the
first subpopulation of rcd2 pedigrees. No ancestors were identified that were common to all 3
sets of pedigrees, within at least 13 generations (data not shown).
Because dogs from all three subpopulations had been used in development of the rcd2-
informative collie-derived pedigrees, it was known that the diseases segregating in each of
these lines were at least allelic, and probably represented inheritance identical-by-descent of
a single allele from a much more ancient ancestor common to all 3 subpopulations.
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I.2. b. Haplotype Analysis and LD mapping: To identify ancestral SNP haplotypes in phase
with the rcd2 disease allele, 38 informative SNPs from the 2.57 Mb candidate region defined
in the Figure 1B, with an average inter SNP distance of 45 Kb, were retrieved from the canine
SNP database (http://www.broad.mit.edu/mammals/dog/snp) (Figure 1B; Supplementary
Table 1). The SNPs were amplified and sequenced for a subset of rcd2-affected and -
heterozygous dogs representing each of the 3 lines of descent described above.
Examination of the resulting SNP genotypes of rcd2-affected collie dogs representative of the
3 identified subpopulations revealed that all were homozygous throughout an extensive LD
region (> 2Mb) surrounding the rcd2 locus, but the haplotypes compared between dogs differed
markedly. (Figure 1B; Columns I–IV)
Dog I in Figure 1 was homozygous for (and thus demonstrates) the haplotype characteristic of
the majority of rcd2-affected pedigreed collies, belonging to that subpopulation described
above with pedigrees characterized by inbreeding loops involving recent common ancestors.
Dog II in Figure 1 also belongs to the same subpopulation as Dog I, and shares the same
genotype for all markers centromeric to SNP239. At SNP239 and further telomeric SNPs,
however, this dog is heterozygous, clearly presenting evidence of an historic recombination
event. Dogs III and IV in Figure 1 came from very different subpopulations, both from each
other, and from Dogs I and II. Both dogs are homozygous for all SNPs within the tested interval,
but their haplotypes are very different, both from each other, and from Dogs I and II.
The only interval in which all affected dogs shared identical alleles at all SNP loci was between
SNP206 and SNP227. The boundaries of this region of common absolute LD, defined by
flanking SNP196 centromerically and SNP239 telomerically, thus reduced the rcd2 candidate
interval to less than 564 Kb.
I.3 Comparison of LD and meiotic linkage mapping results—The minimal common
absolute LD region, identified above, thus exceeded 563 Kb, but its centromeric boundary was
more distal (telomerad) than the corresponding limit identified by meiotic linkage mapping.
The 308 Kb zero recombination interval, on the other hand, established a telomeric boundary
that was further proximal (i.e. centromerad) that one defined by LD mapping. The overlap of
these results jointly reduced the rcd2 candidate region to an approximately 230 Kb interval
bounded by SNP206 at the centromeric end (from LD analysis), and FH3972 at the telomeric
end (from meiotic linkage analysis). This interval corresponded to CFA7:12,724,381–
12,950,649 on CanFam2, which included 3 known genes: TRAF5, C1orf36 (RD3), and
SLC30A1.
II. Analysis of TRAF5 and SLC30A1 genes as positional candidates genes for rcd2
II.a. TRAF5—An entire open reading frame of the TRAF5 gene was amplified from the retinal
cDNA of one normal and one rcd2 affected dog and sequenced. Comparison of the TRAF5
sequences detected one nucleotide difference between normal and rcd2 affected individuals.
This polymorphism would not cause changes in the canine TRAF5 open reading frame.
Alignment of the canine and human TRAF5 transcripts revealed 86% identity. The structure
of the canine TRAF5 ortholog did not differ significantly from that of the human or mouse gene
(data not shown).
II.b. SLC30A1—Partial screening of the coding region of the canine SLC30A1 gene (1,708
bp) was performed by amplification of retinal cDNA and gDNA from normal and rcd2 affected
individuals. Sequence comparison identified several SNPs in the coding region of the canine
SLC30A1 that were not associated with the disease (data not shown).
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III. The canine RD3 gene and transcripts
The canine gene homologous to C1orf36 / RD3 was identified as annotated but incomplete on
the reverse strand of CFA7 in CanFam2 between 12,847,668 and 12,831,626. This canine
assembly included a 1,552 bp gap (CFA7:12,832,685–12,834,236) downstream from the
region homologous to the first coding exon of the human gene (human exon 2). Alignment of
sequence from the canine assembly with human and mouse demonstrated that the putative dog
sequence appeared to be missing regions present in human and mouse, and could not be fully
aligned to human coding sequence.
As described below, the canine gene proved, eventually, to comprise 6 exons, that are
differentially spliced to yield 3 splice variants (Figure 3). Noncoding exon 1 of the dog
corresponds to exon 1 of mouse and human, noncoding canine exon 2 does not appear to have
a homolog in the other 2 species, and the first coding exon in the dog was canine exon 3
(corresponding to exon 2 of the human and mouse genes). Canine exon 4 (corresponding to
exon 3 of the human and mouse genes, and the terminal coding exon in human and mouse)
was apparently missing from the CanFam2 assembly. Canine exons 5 and 6 do not correspond
to identified human or mouse exons.
III.a. RD3 splice variants number 1, 2 and 3—The initial canine RD3 transcripts were
amplified and sequenced from retinal cDNA of a 10.4 week old normal dog, by 5’and 3’ RACE-
PCR using primers 36R1A and 36F9, respectively (Table 2A), both located in the first coding
exon and designed to produce overlapping 5’ and 3’ RACE amplicons. The coding sequence
obtained by RACE was then confirmed using RT-PCR with primers 36F18 and 36R16. Blast
of the resulting canine RD3 cDNA sequence against canine genomic DNA showed that this
transcript comprised four exons which when aligned against CanFam2 were flanked by
consensus splice donor and acceptor sites. This initially identified splice variant was predicted
to encode a 99 amino acid protein with a start codon located in exon 3 and a stop codon located
after the first base of the fourth exon of the transcript. The predicted length of canine protein
was less than that of either the mouse or human, both of which comprise 195 amino acids. The
exons comprising the dog transcript were eventually recognized as canine exons 1, 2, 3, and 6
(Figure 3A). The transcript did not include a canine homolog of the mouse and human exon 3
(Friedman et al., 2006, Figure 3, Supplementary Fig. 2) that would correspond to exon 4 in
dog.
Amplification of normal retinal cDNA with primer pair 36F18 and 36JR2 identified a second
splice variant (Figure 3B; Supplementary Fig. 2). This variant included exons 1, 2, 3, and a
part of a new terminating exon eventually identified as canine exon 5. Alignment against
genomic sequence confirmed that identified exons were flanked by consensus splice donor and
acceptor sites. The sequence corresponding to exon 5 in this variant comprises 269 bp but this
transcript likely extends beyond position of the primer 36JR2. This splice variant (number 2)
was predicted to encode a 108 amino acid protein with a start codon located in exon 3 and a
stop codon located after the first 28 bases of exon 5.
Based on the strong conservation of the second coding exon of RD3 among six mammalian
species (Figure 4), we hypothesized that a canine RD3 splice variant that includes the ortholog
of this exon (exon 3 in human and mouse) should exist in the canine retinal transcriptome. We
further hypothesized that absence of this transcript from the above RACE results might be
caused by competition among several splice variants for shared primers, and/or because of the
GC-richness of this exon in humans and mouse (68% and 66% GC respectively). Because this
region of the canine RD3 gene is not present in the CanFam2 assembly, a human sequence
primer (36e2R2) was designed from alignment of human and mouse exons 3, and used in
conjunction with primer 36F2 (canine sequence, canine exon 1) to amplify normal canine
retinal cDNA by RT-PCR. This yielded a 458 bp product that was highly similar to human and
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mouse RD3 exons 2 and 3 (Figure 4). Because this new, but partial splice variant (splice variant
3) clearly established the existence of canine exon 4 (canine homolog of human and mouse
exon 3), which was not present in the CanFam2 assembly, we proceeded to sequence the two
plasmids p166-18 and p417–19 (Supplementary Fig. 1; Supplementary Table 3). As described
in the Methods, section V, these plasmids were subcloned from 2 canine BAC clones, and were
expected to cover the 1,552 bp gap region in the CanFam2 assembly. Subcloning and
sequencing of these genomic fragments from the BAC clones have been pursued because
multiple attempts to obtain this sequence using long range PCR have been unsuccessful.
Sequence obtained from these plasmids included the newly identified canine RD3 exon 4 and
its flanking region (NCBI Accession: EU687745).
Using forward primer 36F18 (located in canine exon 1), and reverse primer 36BACR2, located
in the predicted 3’ UTR downstream of the stop codon in newly identified canine exon 4, a
more complete version of splice variant number 3, that covered the entire CDS and partial 3′
UTR, was amplified from normal retinal cDNA by RT-PCR. This splice variant contains exons
1, 2, 3, and 4 (Figure 3C) and is predicted to encodes either a 200 or 202 amino acid protein
-- a polymorphic repeat identified in exon 4 of several normal dogs (2 versus 3 copies of a
hexamer repeat; Figure 5; Supplementary Fig. 2) determines the predicted deletion or insertion
of two amino acids (arginine, proline).
III.b. Identification of the rcd2 mutation—Attempts to amplify fragments of canine
RD3 from affected dogs were initially highly inconsistent. One primer pair (36F18, 36JR3)
robustly amplified retinal cDNA from both normal and rcd2 affected individuals. Primers
downstream from 36JR3, however, failed to amplify an affected amplicon either by RT-PCR
of cDNA, or by genomic PCR.
Because the normal allele of canine RD3 exon 4 is over 80% GC-rich, we hypothesized that a
mutation in the corresponding affected allele might be responsible for the difficulty in
amplification of this region. To address this possibility, we deaminated genomic DNA from
normal, rcd2 affected, and rcd2 carrier dogs using EZ Methylation-Gold Kit (Zymo Research,
CA). Deaminated DNA was amplified with primers RD3NH3F1/ RD3NH3R1 and sequenced.
Complete absence of cytosine residues in the final sequence indicated that deamination was
complete. Comparison of deaminated sequences revealed a 22 bp insertion in the affected
amplicon, that causes a frame shift and continues the open reading frame beyond the normal
stop codon.
To retrieve further downstream sequence of the disease allele of splice variant 3, PCR was
undertaken on genomic DNA from an affected dog using four primer sets (36e2F7og/
36BACR2, 36e2F30/36e2R30, 36e2F30/36e2R31, 36e2F30/36e2R32). Assembled sequence
from the resulting overlapping fragments included the continuation of canine exon 4 and a part
of the 3’UTR of splice variant 3, but sequencing failed consistently for regions downstream of
primer 36BACR2, located 39 bp downstream from the normal stop codon. Comparison of the
coding sequences of RD3 splice variant 3 from normal and rcd2 affected dogs predicts that the
22 bp insertion changes the last 61 amino acids of the encoded protein (Figure 5). From analysis
of genomic DNA sequence representing the normal 3’UTR sequence for this splice variant,
the affected transcript is predicted to encode a total of 574 amino acids.
IIIc. RD3 expression in normal and mutant canine retinas—Northern analysis was
undertaken to examine RD3 expression in normal and rcd2 affected canine retinas at different
stages of postnatal development. In normals there was an abundant transcript over 2.37 Kb
detected as early as 1.9 weeks of age (the earliest time point studied), the time when
photoreceptors just beginning to differentiate in the central retina; the highest level of
expression was detected at 6.4 weeks of age, when retinal differentiation is near completion
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(Aguirre et al. 1982; Acland and Aguirre 1987; Figure 6). Trace amounts of a similarly sized
RD3 transcript was observed in all lanes from rcd2-affected retina (Figure 6). Less abundant
signals corresponding to about 4.4 and about 7.5 Kb were also observed in both normal and
affected RNA samples. There was no significant difference in intensity of these signals between
normal and affected dogs. Hybridization with a β-actin probe was used to permit comparison
of RNA loading between lanes.
IV. Population analysis of RD3 mutation
To confirm that the RD3 insertion co-segregated with the rcd2 disease phenotype we genotyped
individuals from several rcd2 informative pedigrees using primers RD3NH3F1 and
RD3NH3R1 (Table 2B). Complete co-segregation of the RD3 insertion allele with the rcd2
phenotype was observed (Figure 2B).
To test this association further, a population study was undertaken using 18 rcd2-affected, 13
obligate heterozygous, and 49 clinically nonaffected pedigreed collie dogs that were neither
part of, nor closely related to the primary study population, and a further 61 clinically
nonaffected dogs representing 19 other (i.e. non-Rough or Smooth collies) breeds. All rcd2
affected dogs were homozygous for the RD3 insertion, all obligate carriers carried both normal
and affected alleles, one clinically nonaffected collie dog was heterozygous, and all other
clinically nonaffected dogs tested were homozygous for the normal RD3 allele. (Table 3,
Supplementary Table 4).
Discussion
To fine map the canine rcd2 interval, a combination of meiotic linkage and linkage
disequilibrium mapping was instrumental in reducing the candidate interval to manageable
proportions. This was successful in concentrating attention to the canine homolog of C1orf36 /
RD3, and led to identification of the insertion proposed as the causative mutation. At the same
time, this effort brought into focus critical issues in undertaking LD/association studies in a
canine population.
Fine mapping by meiotic linkage analysis was undertaken using 42 mixed-breed backcross and
intercross pedigrees derived from multiple rcd2-affected founders, including 266 offspring in
the informative generation. These pedigrees were densely mapped with a set of polymorphic
microsatellite markers across the previously identified rcd2 zero recombination interval
(Kukekova et al. 2006). This effort reduced the rcd2 interval to ~308 Kb, with the centomerad
boundary of the new interval defined by a single observed recombinant event.
Simultaneously, a SNP genotyping effort was undertaken to identify haplotypes cosegregating
with the rcd2 disease allele. The set of rcd2-affected individuals to genotype was selected based
on ancestry analysis. The pedigrees of most rcd2-affected collies all shared a small number of
ancestors contributing to both their maternal and paternal lines of descent within recent (4 to
10) generations. Several such dogs were among the founders of the rcd2-informative collie-
derived pedigrees used in this study. In contrast, two rcd2-affected pedigreed collies that were
also used in the study colony, were outliers. They were each the result of an inbred mating, but
their pedigrees included none of the dogs previously identified as common ancestors in rcd2
segregating pedigrees and, including these 2 dogs in the analysis, no ancestors common to all
lines of descent were identified within at least 13 generations.
The SNP genotyping results were initially surprising. Comparison of genotypes representative
of the majority of rcd2-affected pedigreed collies (Figure 1B, Dog I), with those of the 2 outlier
dogs (Figure 1B, Dogs III and IV) revealed that all these dogs were homozygous for all SNPs
tested over at least 2.5 Mb. However, the haplotypes differed significantly among these dogs.
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As fine mapping of the rcd2-interval with SNPs continued, concentrating on the zero
recombination interval, a minimal common LD region emerged in which the same haplotype
was shared by all rcd2-affected dogs. One rcd2-affected collie (Figure 1B, Dog II) from the
same subpopulation as Dog I revealed an historic recombination event between SNP227 and
SNP239, that defined the telomeric end of the common absolute LD interval. The centromeric
end of the absolute LD interval was also defined by a historical recombination between SNP196
and SNP206 (see Dog III, Figure 1B) making the length of this interval approximately 563 Kb.
Comparison of meiotic linkage analysis and LD results reduced the final rcd2 candidate interval
to about 230 Kb - a region that included only three recognized genes. This demonstrates the
efficiency of applying a combination of linkage and LD mapping for high resolution mapping
a monogenic trait in dogs and highlights advantages and limitations of both approaches.
Linkage analysis in canine populations is frequently limited by the availability of suitable
informative pedigrees, particularly for purposes of fine mapping, and, in some cases, low level
of recombination. To refine a mapped disease locus to an interval less than 1 Mb, pedigrees
with well over 200 informative progeny may be required. Such pedigrees are rarely available
-- in the present study the pedigrees were derived from carefully bred colony dogs, and could
be expanded relatively rapidly as needed, but such a resource is not generally available for the
majority of traits segregatig in dogs. As our data shows, however, once a phenotype is mapped
to a broad interval, LD mapping of a few carefully selected individuals can reduce the interval
dramatically even if the disease is observed in a single breed.
The reported extensive LD within dog breeds has been broadly taken to indicate that genome
wide association studies can be undertaken at relatively low resolution within a single canine
breed, and then refined using the narrower LD between breeds. Indeed, this approach has had
several notable successes (Goldstein et al. 2006; Zangerl et al. 2006; Parker et al. 2007;
Karlsson et al., 2007; Sutter et al. 2007). However, the present study indicates that such a
strategy could well fail for a disease like rcd2 that segregates within a single breed. On the
other hand, our study shows that by careful selection of dogs to genotype based on pedigree
analysis, that a two stage LD analysis can be effective, even within a single canine breed. A
low resolution association study to detect LD -- for example. using currently available resources
for genome wide SNP-based association studies in dogs (Karlsson et al., 2007) --would
probably have failed to identify the rcd2 associated region if it included a mixture of dogs like
dogs I, III, and IV in Figure 1. But a structured association study looking first at the dogs with
recent common ancestors, and subsequently and separately at the least related rcd2-affected
dogs, would have been successful.
This observation confirms a growing recognition (Goldstein et al. 2006; Parker et al. 2007;
Quignon et al. 2007; Bjornerfeldt et al. 2008) that pedigree structure within dog breeds can
increase the power of association mapping studies. Several recent studies have shown that even
for diseases observed in multiple breeds, the LD interval can be reduced by comparison of
haplotypes of carefully selected, least related individuals from one breed to an extent
comparable to that achieved by comparison of haplotypes across multiple breeds. As examples,
the minimal LD interval for CEA, a disease recognized in multiple dog breeds, was reduced
to 103 Kb mostly by haplotype comparison among unrelated affected Border Collies (Parker
et al. 2007); the LD interval for prcd, another multibreed disease, was reduceable to 106 Kb
largely by comparison of haplotypes of unrelated Australian Cattle Dogs and Toy Poodles from
different countries (Goldstein et al. 2006); and in the Golden Retriever breed, with a large
population and diverse pedigree structure, selection of dogs originating from different
geographical regions was able to yield a 25% decrease in LD, comparable to the LD reduction
when haplotypes from two distinct breeds were combined (Quignon et al. 2007). In the current
study a dramatic reduction of the rcd2 interval was achieved with only three samples of the
same geographical origin from one breed. This demonstrates that a disease segregating in just
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a single breed can be mapped efficiently by LD mapping, if breed size, structure, and history
are appropriately taken into account. Similar mapping strategy can be predicted to be applicable
for other species with well established breed structure (Gautier et al. 2007; Menotti-Raymond
et al. 2008; O’Brien et al. 2008; Amaral et al. 2008).
The canine RD3 gene has several features unlike that of the corresponding human and mouse
genes. Not only are there additional exons and splice variants detected in the dog, but the
extreme GC richness of canine exon 4 (corresponding to human and murine exon 3) also posed
challenges for cloning and sequencing. The latter issue presumably accounts for the gap (CFA7:
12,832,685–12,834,236) in CanFam2 corresponding to this part of the genomic sequence. This
sequence, eventually retrieved from BAC clones, posed even greater difficulties for screening
rcd2-affected dogs. However, sequencing this exon from normal and rcd2 affected dogs after
amplification of deaminated DNA identified a 22 bp insertion in the disease allele.
Three canine RD3 retinal splice variants were identified (Figure 3, Supplementary Fig. 2), only
one of which (splice variant 1) has as yet a completely sequenced 3’UTR, as assessed by the
identification of a poly-A tail. How far the 3’ UTR of transcripts 2 and 3 extend is unclear, as
attempts to RACE-PCR amplify them failed, and the presently reported 3’ end of sequence for
each of these splice variants is truncated by the RT-PCR primer.
Repeated attempts to sequence the disease allele of exon 4 retrieved only 39 bases downstream
from the normal stop codon. Because the reading frame remained open through exon 4 to this
point, it is clear that the insertion alters the predicted peptide sequence corresponding to the
last 61 amino acids of the normal protein, and may add a further 372 amino acids, if one assumes
that the further downstream sequence of the exon 4 disease allele is the same as in the normal
allele.
Northern analysis revealed one abundant RD3 transcript, ~2.4 Kb, in retinal RNA of normal
dogs at all developmental stages tested (Figure 6). Only trace amounts of this transcript were
detected in rcd2 affected individuals. Further larger bands, about 4.4 and 7.5 Kb, were also
observed on the northern, but their intensity did not vary significantly among samples
representing different developmental stages, nor between normal and affected individuals;
additional studies would be required to verify which band corresponds to which splice variant.
However, based on the difference between normal and affected seen in northern analysis, the
~2.4 Kb band probably corresponds to splice variant 3, which is the only one containing the
disease-causing insertion. We hypothesize that this transcript may either be unstable in affected
dogs, or its high GC content makes it difficult for the cell to transcribe.
Detection of three splice variants of canine RD3 gene differs from reports on human and mouse
RD3 in which only a single transcript was described (Lavorgna et al. 2003; Friedman et al.
2006). The RD3 transcript is detectable in mouse retinal RNA at a very low level at E12 with
an increase in expression at E18, and a further increase at P2 and P6, after which expression
level remains high (Friedman et al. 2006). In normal dogs, the lowest expression level of the
~2.4 Kb RD3 transcript was observed at 1.4 weeks of age (the earliest time point studied) with
levels increasing to 7 weeks postnatal, when photoreceptor differentiation is approaching
maturity in the canine retina (Acland and Aguirre 1987). The presence of several RD3
transcripts in the canine retina may suggest that the RD3 gene has several functions in the
retina.
A C319T mutation in exon 3 of the mouse RD3 gene, resulting in a predicted stop codon after
residue 106, has been reported as the causative mutation for the rd3 mouse phenotype
(Friedman et al. 2006). Canine exon 4 -- mutated in rcd2, and mouse exon 3 -- mutated in
rd3 -- are orthologous. RD3 mutations have also been reported in two human patients, siblings,
both affected with the early onset retinopathy Leber congenital amaurosis; in these cases
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mutations were present in the donor splice site at the end of human exon 2 (Friedman et al.
2006).
The function of the RD3 gene is not well understood. In silico analysis of mouse and human
RD3 proteins revealed a coiled-coil domain at amino acids 22–54 and another weaker coiled-
coil domain at aa 121–141. Several putative protein kinase C and consensus Casein kinase II
phosphorylation sites and one predicted sumoylation site have been identified in the RD3
protein (Friedman et al. 2006). In transfected COS-1 cells, the RD3-GFP–fusion protein
primarily exhibits nuclear or nuclear / cytoplasmic localization in close proximity to
promyelocytic leukemia (PML) bodies (Friedman et al. 2006). Identification of the mutation
responsible for rcd2 reinforces the significance of the role that RD3 plays in retinal function
and development, although the specific functions need to be identified.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. High resolution meiotic linkage (A) and linkage disequilibrium (B) maps of the rcd2
interval on canine chromosome 7
A. The map order of 9 microsatellites is indicated with their sequence locations in the CanFam2
assembly of the canine genome. For microsatellites FH2226, CPH20, FH3972 and VIASD10
the number of recombination events observed, between each marker and rcd2, per total number
of informative individuals analyzed (126), is listed in parentheses below each marker’s name.
SYT14, SERTAD4, KCNH1 and rcd2ms6 all cosegregated with each other, sharing 1 observed
recombination with rcd2. Marker rcd2ms3 cosegregated with rcd2 with no observed
recombinations.
B. CanFam2 locations and identifying names are listed for 38 SNPs identified in the rcd2
candidate region, as are genotypes for these SNPs from 4 rcd2-affected pedigreed collie dogs
(I–IV). Shaded regions indicate where all 4 dogs share identical SNP genotypes. The region
encompassed by the dashed box indicates the final rcd2 zero-recombination interval defined
by the locations of markers rcd2ms6 and FH3972. The region boxed with a solid outline
indicates the minimal region of absolute common LD, defined by the locations of SNP196 and
SNP239. The final rcd2 candidate region, representing the overlap of the zero-recombination
and absolute common LD intervals is indicated by SNP genotypes in bold.
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Figure 2. Representative rcd2-informative experimental pedigree
A. Pedigree demonstrates recombination between rcd2 and marker rcd2ms6, the closest marker
recombinant with rcd2. + indicates the wild-type allele and - indicates the rcd2-disease allele.
Haplotype shading indicates parental origin. Allele 4 for marker FH3972 in individual 7,
marked by the asterisk (*) is an example of non-Mendelian inheritance.
B. Cosegregation of the RD3 insertional mutation in this rcd2 pedigree. All affected individuals
(3, 5, 6, 7, 8, 9) show one band (allele 1); all rcd2 carriers (1, 2, 4, 10) show two bands (alleles
1 and 2).
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Figure 3. Identified splice variants of canine RD3 transcripts
Three splice variants of the canine RD3 gene are aligned against sequence locations on canine
chromosome 7 in the CanFam 2 assembly of the dog genome, and compared to the orthologous
human and mouse transcripts. Canine Exon 4 is not present in the CanFam2 assembly, as
indicated by the gap from 12,834,236 tp 12,832,685. Open boxes correspond to the canine
RD3 open reading frames, black boxes correspond to untranslated cDNA. A -splice variant #1;
B - splice variant #2; C - splice variant #3. Not to scale.
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Figure 4. Alignment of canine RD3 exon 4 to the corresponding exon from seven other species
Nucleotides that differ from the human sequence are colored in grey. Two nucleotides in the
dog sequence (positions 122–123) that serve as left and right boundaries of the insertion in the
rcd2 affected dogs are in bold and underlined.
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Figure 5. Canine RD3 coding sequences demonstrating variations among normal and rcd2 affected
dogs
The nucleotide sequence of the wildtype open reading frame is shown with the corresponding
translated amino acid sequence underneath, in italics. The start codon and the normal stop
codon are bolded. The junction of exons three and four is represented by the backslash (G\G).
A hexamer repeat is indicated within square brackets and shaded . Sequence variants with
either two or 3 copies of this hexamer are observed from normal dogs; the rcd2-disease allele
has 2 copies. This hexamer codes for a pair of amino acids (R P), which are thus predicted to
be present twice or 3 times in the translated sequence. The boxed nucleotide  represents a
SNP (S = C or G), both alleles being observed in normal dogs, that changes the coded amino
acid  from proline to arginine. The rcd2-disease sequence has the G allele for this SNP. The
asterisk (*) marks the site (immediately before the polymorphic nucleotide indicated by  )
where a 22 bp sequence ( gcccgcccccgcccccgccccc) is inserted in the rcd2 disease allele.
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Figure 6. RD3 Expression in canine retina
A. Northern blot analysis of RD3 expression in total retinal RNA from normal (lanes 1, 4, 5,
7, 10) and rcd2 affected (lanes 2, 3, 6, 8, 9, 11) dogs at selected postnatal age points. Lanes 1=
1.4; 2 and 3 = 1.9; 4 = 3.3; 5 = 4.3; 6 = 4.1; 7 = 6.9; 8 = 6.4; 9 = 7.9; 10 = 9.7; and 11 = 10.0
weeks of age. Ribosomal RNA is indicated as 28S and 18S. B. Northern analysis of the same
RNA blot with β-actin probe.
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Table 1
Newly designed microsatellite markers and their locations on canine chromosome 7 (CFA7) in the CanFam2 assembly
of the dog genome sequence.
Primer Primer sequence Amplicon location
SYT14F3 ctgcctgtgtctctgcctctctc 11,599,574–11,599,748
SYT14R3 aatgtggagccccattttcaag
SERTAD4F1 acccctttctctccatgctagtgtc 11,816,877–11,817,110
SERTAD4R1 gccttttcctgaacacctagtgacc
KCNH1F3 ggtctttagcttgccaactgcaga 12,568,635–12,568,820
KCNH1R3 ctaacactgaatcagggttgacaga
rcd2ms6F1 tccagaattccttctccatctcag 12,642,574–12,642,844
rcd2ms6R1 tccacagggattttgtctcaaaga
rcd2ms3F1 caaggatgggtcccttaaaacaga 12,841,258–12,841,496
rcd2ms3R1 cagagggtctgacctatggcaagt
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Table 2
RD3 primers used for amplification of canine cDNA (A), for rcd2 mutation
screening (B), and to develop hybridization probes (C). Primers RD3NH3F1 and
RD3NH3R1 were designed for amplification of deaminated DNA.
Primer Sequence (5’ to 3’) Source Location CanFam2.0
A. Primers used to amplify canine RD3 cDNA
36R1A gtggatcttggcacagacgtcctct Canine Canine exon 3 12,835,497–521
36F9 cgcagtaacgcgctcaggaaggtct Canine Canine exon 3 12,835,601–625
36F18 ccaggctggatccctccggtca Canine Canine exon 1 12,847,140–161
36R16 agtcatctgaaggcactccagacct Canine Canine exon 6 12,820,212–236
36JR2 gcagcgactacgcctccaggaacaat Canine 3’UTR v2 12,832,366–391
36e2R2 cgctccacgtcctcggagatggt Human Human exon2
36F2 gtgctggagacgctcatgatgga Canine Canine exon 3 12,835,669–691
36R1 gatcttggcacagacgtcctcta Canine Canine exon 3 12,835,500–522
36e2F3og cggctcttccgctcggtgct Canine Canine exon 4 Missing in CanFam2.0
36e2ogR16 ggcgcccggaattcgggcatg Human Human exon 2
36e2ogR13 cggctttgggcgcccggaattc Human Human exon 2
36BACR2 ggaaggcccgctccctcccgtg Canine 3’UTR v3 Missing in CanFam2.0
36JR3 ctgaatctccagagccgcgacacc Canine Canine exon 4 Missing in CanFam2.0
36e2F7og ctcgcccttcgccggccacatc Canine Canine exon 4 Missing in CanFam2.0
36e2F30 ccccggccctggagcctgcg Canine Canine exon 4 Missing in CanFam2.0
36e2R30 gcaggctccaggtgcgcagc Canine Canine exon 4 Missing in CanFam2.0
36e2R31 cggaactcgggcaggctccaggtg Canine Canine exon 4 Missing in CanFam2.0
36e2R32 cctgcggcgcccggaactcg Canine Canine exon 4 Missing in CanFam2.0
B. Primers used to screen the rcd2 mutation
RD3NH3F1 tgagtgtgagtttgaggtgtatgagg Canine Canine exon 4 Missing in CanFam2.0
RD3NH3R1 cacacacaaaacccacaaaaatcc Canine Canine exon 4 Missing in CanFam2.0
C. Primers used to produce PCR probes for BAC DNA hybridization
RD3F2 gtggtgtccatcctctgctggt Canine Canine exon 5 12,832,565–586
RD3R2 ccctacaggcttcgctgtcctt Canine Intronic sequence 12,832,000–021
RD3F4 tgcaagagcccatagaacacca Canine Intronic sequence 12,835,201–222
RD3R4 gtaaagggatgcagatccaccg Canine Intronic sequence 12,834,685–706
36e2F1c gttccggcagctgctggccga Canine Canine exon 4 Missing in CanFam2.0
36e2ogR16 ggcgcccggaattcgggcatg Human Human exon 2
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Table 3
Test results of mutation screening in a population of rcd2 affected, carrier, and normal dogs.
rcd2 status Affected Obligate carriers Clinically nonaffected Collies Clinically
nonaffected dogs,
other breeds
Number of chromosomes
tested
36 26 98 122
Number of RD3 insertion
alleles identified
36 13 1 0
Mamm Genome. Author manuscript; available in PMC 2010 February 1.
